VRN110755

DRUG2 trials

Sponsors

Voronoi, Inc

Conditions

EGFR-Mutant Non-Small Cell Lung CancerHealthy

Phase 1

A Study to Evaluate the Effect of Food and a Proton Pump Inhibitor on the Pharmacokinetics of VRN110755

CompletedNCT07141381

Voronoi, IncHealthy

Start: 2025-08-27End: 2026-04-16Updated: 2026-05-08

A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

RecruitingNCT07699328

Voronoi, IncEGFR-Mutant Non-Small Cell Lung Cancer

Start: 2024-03-26End: 2029-01-01Target: 315Updated: 2026-07-13